Post #11101

Hyperliquid Strategies submitted an S-1 filing with the SEC to raise $1B Hyperliquid Strategies plans to offer up to 160M shares of its common stock for the raise. The company plans to use the proceeds for general corporate purposes, including the accumulation of HYPE. Chardan Capital Markets is serving as its financial advisor for the offering. The company is a pending merger entity formed by Sonnet BioTherapeutics and Rorschach I, aiming to launch within this year. 🔗theblock.co/post/375812/hyperliquid-strategies-1-billion-raise Follow us to be on top of crypto: TG | Chat | X